Leflunomide Sandoz

Leflunomide, the active ingredient in Leflunomide Sandoz, is an immunomodulatory disease-modifying antirheumatic drug presented as an oral tablet for systemic use. It is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis in adult patients requiring disease-modifying therapy. It offers a convenient once-daily dosing regimen that helps control disease activity and improve functional outcomes.

GNH USA supplies Leflunomide Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to global quality standards and provides regulatory‑approved batches to meet the needs of diverse healthcare settings.

Leflunomide is a disease-modifying antirheumatic drug used to manage inflammatory joint diseases.

- Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriatic arthritis: alleviates skin and joint symptoms and limits disease progression. - Active disease despite methotrexate therapy: serves as an alternative DMARD to achieve disease control.

Leflunomide may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Alopecia: reversible hair thinning. - Rash: skin irritation or erythema. - Elevated liver enzymes: mild transaminase rise. - Hypertension: increase in blood pressure readings.

Serious or Rare Side Effects: - Severe liver injury: potential hepatic failure. - Stevens‑Johnson syndrome: rare severe skin reaction. - Bone marrow suppression: pancytopenia risk. - Interstitial lung disease: pulmonary inflammation. - Severe infections: opportunistic bacterial or viral infections. - Teratogenicity: fetal malformations if exposure occurs during pregnancy.

Before initiating therapy, several safety considerations should be observed. - Monitor liver function: obtain baseline and periodic LFTs. - Monitor blood pressure: watch for hypertension development. - Avoid in pregnancy: contraindicated; ensure effective contraception. - Assess infection risk: screen for active infections prior to start. - Discontinue if severe liver injury occurs: stop treatment immediately. - Store below 25°C: keep in the original pack, protect from moisture.

Leflunomide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may increase INR and bleeding risk. - Hepatotoxic drugs (e.g., methotrexate): additive liver toxicity. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - Statins: increased risk of myopathy. - Oral contraceptives: reduced hormonal efficacy. - NSAIDs: additive gastrointestinal irritation and renal effects.